What is it about?

China and other countries in the world attach great importance to Drug Quality and Sampling Testing work . In recent years, China has implemented a series of medical reform policies. Therefore, we analyzed the influence of China's medical reform policy on Drug Quality and Sampling Testing work , and analyzed the problems of Drug Quality and Sampling Testing work under the situation of medical reform.

Featured Image

Why is it important?

This study analysed the high risk drugs that should be included in the list of drug survey candidates based on the healthcare reforms in China for the first time. This provides a new perspective for drug sampling and testing using a risk based approach globally. Moreover, we provided an overview of the current drug sampling and testing status in China and analysed the problems of the drug sampling and testing programme based on the healthcare reform in China. This provides a reference for improving the efficiency of the drug sampling and testing programme in China.

Perspectives

I hope that this study will attract scholars with expertise in these fields to conduct more research in this important applied area, thus providing a reference for improving the efficiency of drug sampling and testing programs in China.

Shiqi Li
Shenyang Pharmaceutical University

Read the Original

This page is a summary of: Analysis of the problems of drug sampling and testing programme under tripartite system reform in China, Journal of Evaluation in Clinical Practice, June 2022, Wiley, DOI: 10.1111/jep.13725.
You can read the full text:

Read

Contributors

The following have contributed to this page